(Q71788190)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578856%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578856%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Clinical Significance of Anticardiolipin Antibodies in Patients with Systemic Sclerosis (English)

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

20 May 2024

author name string

U. Picillo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578856

20 May 2024

S. Migliaresi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578856

20 May 2024

M. R. Marcialis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578856

20 May 2024

A. M. Ferruzzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578856

20 May 2024

G. Tirri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7578856

20 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7578856

20 May 2024

publication date

1 January 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578856%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

http://www.tandfonline.com/doi/pdf/10.3109/08916939508993333

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

20 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578856%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578856%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578856%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

1-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578856%20AND%20SRC:MED&resulttype=core&format=json

Vascular Disease in Progressive Systemic Sclerosis (Scleroderma)

21 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

20 May 2024

5

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

20 May 2024

6

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion

20 May 2024

7

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus. Relationships with clinical manifestations and disease activity in an Italian series

20 May 2024

8

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes

20 May 2024

11

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Low functional and high antigenic antithrombin III level in a patient with the lupus anticoagulant and recurrent thrombosis

20 May 2024

12

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis

20 May 2024

13

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant

20 May 2024

14

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases

20 May 2024

15

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Anticardiolipin antibodies in systemic sclerosis

20 May 2024

16

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Immunological abnormalities in a group of patients with limited cutaneous systemic sclerosis and prominent vascular disease

20 May 2024

21

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

20 May 2024

23

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Elevated von Willebrand factor antigen in systemic sclerosis: relationship to visceral disease

20 May 2024

25

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study

20 May 2024

26

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Nervous system involvement in association with vasculitis and anticardiolipin antibodies in a patient with systemic sclerosis

20 May 2024

29

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Antiphospholipid antibodies in mixed connective tissue disease.

20 May 2024

30

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Pulmonary hypertension in MCTD: report of two cases with anticardiolipin antibody

20 May 2024

31

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Anticardiolipin antibodies in rheumatoid arthritis

20 May 2024

32

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Syndrome of the black swan

20 May 2024

34

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Large vessel occlusive disease associated with CREST syndrome and scleroderma

20 May 2024

38

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody-dependent cellular cytotoxicity

20 May 2024

42

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin

20 May 2024

43

1 reference

https://api.crossref.org/works/10.3109/08916939508993333

20 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7578856%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference